Evidence map›Paper›PMID 41419421›Full record

ArticleNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2026

Combining interictal and ictal low-density EEG source imaging to delineate the epileptogenic zone in young children.

Roberto Santalucia, Carlotta Carosio, Antonio Giulio Gennari, Amir G Baroumand, Pascal Vrielynck, Alexane Fierain, Antoine Guilmot, Vincent Joris, Susana Ferrao Santos, Enrique Germany Morrison and 3 more

Abstract read
In one paragraph

Article in Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Roberto SantaluciaCliniques Universitaires Saint-Luc, Paediatric Neurology Unit, Brussels, Belgium; Institute of Neurosciences (IoNS/NEUR), Université Catholique de Louvain (UCLouvain), Brussels, Belgium; Cliniques Universitaires Saint-Luc, Reference Center for Refractory Epilepsy (CRE), Brussels, Belgium; Member of European Reference Network EpiCARE. Electronic address: roberto.santalucia@saintluc.uclouvain.be.
Carlotta CarosioUniversity Children's Hospital Zurich, Department of Neuropaediatrics, Zurich, Switzerland.
Antonio Giulio GennariUniversity Children's Hospital Zurich, Department of Neuropaediatrics, Zurich, Switzerland; University Children's Hospital Zurich, MR Research Center, Zurich, Switzerland.
Amir G BaroumandMedical Image and Signal Processing, Ghent University, Ghent, Belgium; Clouds of Care NV, Ghent, Belgium.
Pascal VrielynckCliniques Universitaires Saint-Luc, Reference Center for Refractory Epilepsy (CRE), Brussels, Belgium; Member of European Reference Network EpiCARE; Centre Hospitalier Neurologique William Lennox (CHNWL), Clinical Neurophysiology, Ottignies, Belgium.
Alexane FierainCliniques Universitaires Saint-Luc, Reference Center for Refractory Epilepsy (CRE), Brussels, Belgium; Member of European Reference Network EpiCARE; Centre Hospitalier Neurologique William Lennox (CHNWL), Clinical Neurophysiology, Ottignies, Belgium; Cliniques Universitaires Saint-Luc, Neurology Unit, Brussels, Belgium.
Antoine GuilmotMember of European Reference Network EpiCARE; Centre Hospitalier Neurologique William Lennox (CHNWL), Clinical Neurophysiology, Ottignies, Belgium.
Vincent JorisInstitute of Neurosciences (IoNS/NEUR), Université Catholique de Louvain (UCLouvain), Brussels, Belgium; Cliniques Universitaires Saint-Luc, Reference Center for Refractory Epilepsy (CRE), Brussels, Belgium; Member of European Reference Network EpiCARE; Cliniques Universitaires Saint-Luc, Neurosurgery Unit, Brussels, Belgium.
Susana Ferrao SantosInstitute of Neurosciences (IoNS/NEUR), Université Catholique de Louvain (UCLouvain), Brussels, Belgium; Cliniques Universitaires Saint-Luc, Reference Center for Refractory Epilepsy (CRE), Brussels, Belgium; Member of European Reference Network EpiCARE; Cliniques Universitaires Saint-Luc, Neurology Unit, Brussels, Belgium.
Enrique Germany MorrisonInstitute of Neurosciences (IoNS/NEUR), Université Catholique de Louvain (UCLouvain), Brussels, Belgium; WELBIO Department, WEL Research Institute, Avenue Pasteur 6, 1300, Wavre, Belgium.
Pieter van MierloMedical Image and Signal Processing, Ghent University, Ghent, Belgium; Clouds of Care NV, Ghent, Belgium.
Georgia RamantaniUniversity Children's Hospital Zurich, Department of Neuropaediatrics, Zurich, Switzerland.
Riëm El TahryInstitute of Neurosciences (IoNS/NEUR), Université Catholique de Louvain (UCLouvain), Brussels, Belgium; Cliniques Universitaires Saint-Luc, Reference Center for Refractory Epilepsy (CRE), Brussels, Belgium; Member of European Reference Network EpiCARE; Cliniques Universitaires Saint-Luc, Neurology Unit, Brussels, Belgium; WELBIO Department, WEL Research Institute, Avenue Pasteur 6, 1300, Wavre, Belgium.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The aim of this study was to evaluate the feasibility of low-density (LD) interictal (IIC) and ictal (IC) electrical source imaging (ESI), and to assess their individual and combined diagnostic accuracy and predictive value in a cohort of children with drug-resistant epilepsy (DRE) who underwent resective surgery before the age of 7. Retrospective analysis was conducted on de-identified EEG and MRI data, which were (semi)-automatically processed, blinded to clinical information, to compute both IIC and IC-ESI. The concordance of ESI localizations with the resection cavity at sublobar level, and the association with surgical outcome were assessed. Thirty-two children were included. IIC- and IC-ESI showed an accuracy of 66 ​% (CI 95 ​% 47-81 ​%) and 72 ​% (CI 95 ​% 53-86 ​%) and a diagnostic odds ratio (DOR) of 3.0 (CI 95 ​% 0,66-13,69; p ​= ​0,15) and 5.0 (CI 95 ​% 0,91-27,47; p ​= ​0,06), respectively. The combined approach increased diagnostic performance, achieving an overall accuracy of 75 ​% and a DOR of 11.4 (CI 95 ​% 1.08-120,35; p ​= ​0,042). In multivariate logistic regression analysis, the combined IIC/IC ESI result emerged as the strongest predictor of postsurgical seizure freedom (OR: 222,28; p ​= ​0,0262; AUC: 0.87). These findings demonstrate that combined (semi)-automated LD-IIC and IC-ESI is feasible and can accurately localize the epileptogenic zone and predict postsurgical seizure freedom in children under 7 years of age. ESI may support earlier surgical referral, reduce the time from epilepsy onset to surgery, and ultimately improve long-term outcomes.

Indexed as

BrainDrug Resistant EpilepsyElectroencephalographyChildChild, PreschoolFemaleHumansInfantMagnetic Resonance ImagingMaleRetrospective StudiesChildhood epilepsyElectrical source imaging (ESI)Postsurgical outcome

Identifiers

PMID41419421
PMCPMC12976537

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.